Plain-English translation of NCT06647888 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Diabetes Mellitus, Type 2 research guide โThis is a real-world study of enavogliflozin, a medication for type 2 diabetes that also helps control high blood pressure or high cholesterol. Instead of being in a strict research setting, you would simply continue your normal medical care while the research team collects information from your doctor's records over about 6 months. The goal is to understand how well this medication works and how safe it is when used in everyday practice.
Many diabetes medications work well in controlled research settings, but doctors want to know how they perform in real life โ with real patients who have different health situations and take other medicines. This study will help doctors understand whether this medication is both effective and safe for people like you.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would simply take the medication as your doctor prescribes and continue with your regular medical visits. There are no required extra appointments or tests for this study. The research team will gather information from your doctor's medical records โ things like your blood sugar levels, blood pressure, and cholesterol โ for about 24 weeks. This is a low-burden way to help doctors learn about how the medication works in practice.
AI-generated summary from trial data ยท Jun 1, 2026 ยท Not medical advice
South Korea
Sponsor
Daewoong Pharmaceutical Co. LTD.
Enrollment target
~12,000 participants
Started
December 2024
Primary completion
December 2025
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
19 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Ji Yeon Baeg
Happy Yonsei Family Medicine Clinic
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.